skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Search for: All records

Creators/Authors contains: "Biswas, Ananna"

Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

  1. Parkinson's Disease (PD) impacts millions globally, causing debilitating motor symptoms. While Closed-Loop Deep Brain Stimulation (CL-DBS) has emerged as a promising treatment, existing systems often suffer from high energy consumption, making them impractical for wearable or implantable devices. This research introduces an innovative neuromorphic approach to enhance CL-DBS performance, utilizing Leaky Integrate-and-Fire (LIF) neuron-based controllers to adaptively modulate stimulation signals based on symptom severity. Two controllers, the on-off LIF and dual LIF models, are proposed, achieving significant reductions in power consumption by 19% and 56%, respectively, while enhancing suppression efficiency by 4.7% and 6.77%. Additionally, this work addresses the scarcity of datasets for PD symptoms by developing a novel dataset featuring neural activity from the subthalamic nucleus (STN), incorporating beta oscillations as key physiological biomarkers. This dataset aims to support further advancements in neuromorphic CL-DBS systems and is openly shared with the research community. By combining energy-efficient neuromorphic controllers with a comprehensive dataset, this study not only advances the technological feasibility of CL-DBS systems for PD treatment but also provides a foundation for personalized and adaptive neuromodulation therapies, paving the way for improved quality of life for individuals with Parkinson's Disease. 
    more » « less
    Free, publicly-accessible full text available April 23, 2026